2 Unstoppable Growth Stocks to Buy and Hold for the Next Decade

Core Viewpoint - Investing in growth stocks with a long-term mindset can lead to significant wealth accumulation, highlighting two companies with strong expansion prospects: Eli Lilly and Tesla [1] Group 1: Eli Lilly - Eli Lilly's new weight-loss drug, Zepbound, is positioned to address obesity, which affects nearly 70% of American adults, potentially reducing risks for diseases like diabetes and heart disease [2] - A clinical study indicated that patients taking the highest dose of Zepbound lost an average of 48 pounds over 72 weeks, while also improving cholesterol, blood pressure, and blood sugar levels [2] - Goldman Sachs forecasts that Eli Lilly will dominate a projected $130 billion obesity drug market by 2030, with expected earnings per share growth of 63% annually over the next five years [3] Group 2: Tesla - Tesla is a leader in the electric vehicle (EV) market, with the industry expected to grow from approximately $388 billion in 2023 to over $950 billion by the end of the decade [4] - The company is advancing in autonomous vehicle technology, leveraging AI to enhance its self-driving capabilities, which positions it favorably against competitors [4] - CEO Elon Musk aims to develop a fleet of robotaxis, with estimates suggesting that Tesla's driverless car initiative could generate over $600 billion in revenue by 2029, potentially increasing its stock price to $2,600 per share [5] - Tesla is also working on an AI-powered humanoid robot named Optimus, which could address labor shortages and enhance productivity, with long-term profit opportunities estimated at $1 trillion [5]